市場調查報告書
商品編碼
1467669
2024-2032 年按服務類型(病史和身體報告、出院摘要、手術記錄或報告、諮詢報告等)、技術、採購模式、最終用戶和地區分類的近距離放射治療市場報告Brachytherapy Market Report by Service Type (History and Physical Report, Discharge Summary, Operative Note or Report, Consultation Report, and Others ), Technology, Mode of Procurement, End-User, and Region 2024-2032 |
IMARC Group年,全球近距離放射治療市場規模達8.564億美元。
近距離放射治療,也稱為內部放射治療,是放射治療的一種形式,其中放射線直接通過植入體內癌性腫瘤附近或旁邊的源傳輸。此源產生的伽馬射線聚焦於癌細胞並減少對周圍健康組織的損害。根據疾病及其損害的嚴重程度,近距離放射治療可以低劑量率 (LDR) 或高劑量率 (HDR) 進行。對於 LDR,小型放射性種子會永久植入腫瘤內或腫瘤周圍,而對於 HDR,放射源在每次療程結束時從患者體內移除,並用於高風險癌症的情況。
不同類型癌症盛行率的上升是推動全球市場的關鍵因素之一。近距離放射治療已被證明是治療子宮頸癌、皮膚癌和乳癌的一種極其有效的治療選擇,這對其市場成長做出了重大貢獻。此外,高品質的近距離放射治療設備可以為小腫瘤提供精確且極為局部的放射劑量,這提高了患者和醫療專業人員對治療的接受度。腫瘤治療的技術進步和廣泛的研究和開發(R&D),例如治療新生血管性老年黃斑部病變的試驗,也極大地推動了市場成長。除此之外,全球醫療旅遊的不斷成長,以及人們對近距離放射治療的優勢及其成本效益的認知不斷提高,以及與手術或外照射治療(EBT) 相比治癒率的提高,也顯著推動了市場的發展。
IMARC 集團的最新報告深入洞察了全球近距離放射治療市場,涵蓋了其所有重要方面。內容涵蓋從宏觀市場概況到微觀細節的行業表現、近期趨勢、關鍵市場促進因素和挑戰、SWOT分析、波特五力分析、價值鏈分析等。 、研究人員、顧問、商業策略家以及所有擁有任何利益或計劃以任何方式進軍全球近距離治療市場的人。
The global brachytherapy market size reached US$ 856.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,195.9 Million by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032.
Brachytherapy, also known as internal radiation therapy, is a form of radiotherapy in which radiation is transported directly through a source implanted near or next to the cancerous tumor in the body. The source produces gamma rays that are focused on cancer cells and reduce the damage to surrounding healthy tissue. Brachytherapy is either administered in Low Dose Rate (LDR) or High Dose Rate (HDR) depending upon the severity of the disease and its damage. For LDR, small radioactive seeds are implanted permanently in or around the tumor, whereas, for HDR, radioactive sources are removed from the patient's body at the termination of each session and is used in the cases of high-risk cancers.
The rising prevalence of different types of cancer is one of the key factors driving the global market. Brachytherapy has been proven to be an extremely effective treatment option for cervical, skin and breast cancers, which is contributing significantly to its market growth. Furthermore, the availability of high-quality brachytherapy equipment that provides accurate and extremely localized doses of radiation to small tumors has enhanced the acceptance of the therapy amongst patients and medical professionals alike. Technological advancements in oncology treatments and extensive research and development (R&D), such as trials for treating neovascular age-related macular degeneration, have also provided a significant boost to the market growth. In addition to this, growing medical tourism across the globe, along with increasing awareness about the advantages of brachytherapy and its cost-effectiveness and increasing cure rate as compared to surgery or external beam therapy (EBT), is also significantly driving the market.
IMARC Group's latest report provides a deep insight into the global brachytherapy market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global brachytherapy market in any manner.
IMARC Group provides an analysis of the key trends in each sub-segment of the global brachytherapy market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on service type, technology, mode of procurement and end-user.
History and Physical Report
Discharge Summary
Operative Note or Report
Consultation Report
Others (Pathology Report, Radiology Report, etc.)
EMR/EHR
PACS
RIS
SRT
Others
Outsourcing
Offshoring
Both
Hospitals
Clinics
Clinical Laboratories
Academic Medical Centers
Others
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analyzed the competitive landscape of the market with some of the key players being Acusis Software India Pvt Ltd., Transcend Services, Inc., Naunce Communications, Inc., MModal Global Services Pvt. Ltd., iMedX Information Services Pvt. Ltd., Global Medical Transcription LLC, nThrive Solutions LLC, MTBC (CareCloud, Inc.), Medi-Script Plus and Transtech Medical Solutions LLC.